7AI Stock Overview
Engages in the manufacturing, marketing, distribution, and sale of wellness products in Canada, Europe, Japan, China, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Yooma Wellness Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0005 |
| 52 Week High | CA$0.0005 |
| 52 Week Low | CA$0.0005 |
| Beta | 2.73 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7AI | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.9% | 0.8% |
| 1Y | 0% | -5.6% | 8.6% |
Return vs Industry: 7AI underperformed the German Personal Products industry which returned 12.4% over the past year.
Return vs Market: 7AI underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| 7AI volatility | |
|---|---|
| 7AI Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 3.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7AI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 7AI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Jordan Greenberg | yooma.ca |
Yooma Wellness Inc. engages in the manufacturing, marketing, distribution, and sale of wellness products in Canada, the United States, Europe, and Asia. Its wellness products include hemp seed oil, and hemp-derived and cannabinoid (CBD) ingredients. The company sells its products through various platforms, such as ecommerce, mass-market retail, and independent retail partners.
Yooma Wellness Inc. Fundamentals Summary
| 7AI fundamental statistics | |
|---|---|
| Market cap | €342.61k |
| Earnings (TTM) | -€26.61m |
| Revenue (TTM) | €12.86m |
0.0x
P/S Ratio0.0x
P/E RatioIs 7AI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7AI income statement (TTM) | |
|---|---|
| Revenue | US$14.19m |
| Cost of Revenue | US$10.14m |
| Gross Profit | US$4.05m |
| Other Expenses | US$33.41m |
| Earnings | -US$29.36m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.29 |
| Gross Margin | 28.52% |
| Net Profit Margin | -206.96% |
| Debt/Equity Ratio | 90.3% |
How did 7AI perform over the long term?
See historical performance and comparison